Neurable, a neurotechnology company democratizing BCI technology, announced that it has raised an additional $13 million in funding from Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet. With $30+ million raised since its founding, Neurable is working with its licensing partnership network to make easy-to-use neurotechnology a reality, including through the upcoming launch of the Neurable AI-powered MW75 Neuro headphones.
With this new funding round, Neurable will continue expanding the build of its platform, giving companies and original equipment manufacturers (OEMs) access to its one-of-a-kind and non-invasive BCI technology and making it widely available to consumer audiences. This also includes expanding its product portfolio, reference designs, algorithms, and enabled systems to include earbuds, helmets, and various head-worn devices that will help optimize human performance.
Due to its unique and powerful electroencephalography (EEG) AI technology, which is optimized for more compact form factors than traditional external brain wave monitoring devices, Neurable’s AI-powered platform records wearers’ brain activity. It gives people their brain data in a non-invasive manner.
Launched as a University of Michigan spinout and following its Series A funding in 2020, Neurable partnered with consumer wearable companies, including headphone company Master & Dynamic, to advance the goal of embedding EEG sensors into everyday technologies. This partnership will introduce the first-ever BCI-enabled headphones, MW75 Neuro, set to launch this summer. The new funding round will continue Neurable’s plans to develop its platform technology further to provide consumers with even greater insight into the workings of the brain.
Following the Series A funding round, Neurable partnered with Air Force Research Lab’s 711 Human-Performance Wing to validate Neurable’s technology and explore how it could improve human performance. Building on this successful collaboration, Neurable secured $5 million in contracts from the Department of Defense to further develop this cutting-edge human technology to support soldier health and performance.
KEY QUOTES:
“This new round of funding underscores our commitment to making Neurable’s brain-computer interface technology accessible to everyone. We’re empowering individuals to understand their own mind, optimize human performance, and conquer the most pressing health challenges of our generation.”
– Dr. Ramses Alcaide, CEO and Co-Founder of Neurable
“Neurable’s transformative neurotechnology is at the forefront of the BCI revolution. BCI technology has gained significant momentum over the years, and its advancement shows no signs of slowing down. Neurable’s BCI has the potential to solve a range of vexing issues — from healthcare to daily life. BCI integrated into our devices, and a critical part of our everyday experience was once the stuff of science fiction — thanks to Neurable, that dream will soon be a reality.”
– Dale Davis, Senior Principal at Ultratech Capital Partners
“We’re extremely proud to work with our partners, which include some of the world’s best in consumer technology like Master & Dynamic as well as the very servicemen and women who make sacrifices on a daily basis for the overall security of our nation. This is just the beginning. We can’t wait to show you what’s coming next.”
– Adam Molnar, Co-Founder and Vice President of Strategic Partnerships at Neurable
